Table 3.
Antimicrobial resistance of KPC-, OXA-48 and VIM-producing Enterobacterales.
| Antimicrobial | All isolates (N = 73) |
KPC (N = 41) |
OXA-48 (N = 19) |
VIM (N = 13) |
|---|---|---|---|---|
| Piperacillin-tazobactam | 100% (73/73) | 100% (41/41) | 100% (19/19) | 100% (13/13) |
| Ceftazidime-avibactam | 0% (0/48) | 0% (0/36) | 0% (0/12) | − |
| Ceftazidime | 93.2% (68/73) | 100% (41/41) | 73.7% (14/19) | 100% (13/13) |
| Cefepime | 93.2% (68/73) | 100% (41/41) | 73.7% (14/19) | 100% (13/13) |
| Aztreonam | 81.6% (40/49) | 100% (30/30) | 55.6% (5/9) | 50% (5/10) |
| Ertapenem | 97.3% (71/73) | 100% (41/41) | 100% (19/19) | 84.6% (11/13) |
| Imipenem | 75.3% (55/73) | 100% (41/41) | 21.1% (4/19) | 76.9% (10/13) |
| Ciprofloxacin | 87.7% (64/73) | 97.6% (40/41) | 94.7% (18/19) | 46.2% (6/13) |
| Gentamicin | 76.7% (56/73) | 92.7% (38/41) | 42.1% (8/19) | 76.9% (10/13) |
| Amikacin | 18.3% (11/60) | 11.4% (4/35) | 0% (0/14) | 63.6% (7/11) |
| Cotrimoxazole | 79.5% (58/73) | 95.1% (39/41) | 36.8% (7/19) | 92.3% (12/13) |
| Colistin | 27.4% (20/73) | 24.4% (10/41) | 10.5% (2/19) | 61.5% (8/13) |
| Tigecycline | 11.9% (7/59) | 8.8% (3/34) | 14.3% (2/14) | 18.2% (2/11) |
| Fosfomycin | 23.7% (9/38) | 9.1% (2/22) | 53.8% (7/13) | 0% (0/3) |
Data are presented as percentage (number of resistant isolates/number of tested isolates).